Core products of Yunnan Baiyao, which includ🎉e powder, capsule, aerosol, plaster, woundplast, tincture and hemorrhoids ointment.
Yunnan Baiyao conducted comprehensive and in-depth research on Paris p﷽olyphylla since the year 2000, and h꧑as made significant breakthroughs in breeding technology, cultivation technique, etc, which provide solid guarantee for the company’s sustainable development. Tongshu capsule is also the first Chinese ethnic drug approved by FDA for Phase II clinical trial in US.
·Panax notoginseng saponins
·Sanqi Guanxinning Tablet
·Xuesaitong Injection
·Qiye Shen’an Tablet 🎃
Notoginseജng is a precious medicinal material in Yunnan province. It has a long history of cultivati⛄on and its in-depth development is an important component of Yunnan pharmaceutical industry. Notoginseng Series products are used in preventing heart and cerebrovascular diseases. Xuesaitong Injection has been included in National Essential Drugs List .
·Breviscapine
·Erigerontis injection
·Breviscapine Pills
·Breviscapine Injection
·Yi Maikang Tablet
Erigerontis Herba is originally recorded in the boo🌠k Materia medica in Yunnan Province. Yunnan Baiyao is the earliest unit which carries out systematic research on Erigerontis Herba. It leads the formulation of quality standards for Erigerontis injection and drives the development of the industry. Erigerontis Herba Series products are used in preventing heart and cerebrovascular diseases. Erigerontis injection，Breviscapine𝓡 Injection and Yi Maikang Tablet have been included in National Essential Drugs List.
·The Chinese original drug won the Nobel prize
·As the ꦺmajor research and deve🥃lopment unit (rank the 3rd).
·Solved the botanical 🔴resource, production technology and the first clinical case
A series of pharmacy monographs were compiled and ꦚpublished, which provides samples and fundation🅰 for the development and utilization of new medicine of Yunnan.
